The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma Yunfei LiaoYong FengZhenfeng Duan NON-THEMATIC REVIEW 15 December 2015 Pages: 151 - 163
The promising alliance of anti-cancer electrochemotherapy with immunotherapy Christophe Y. CalvetLluis M. Mir Non-Thematic Review Open access 18 March 2016 Pages: 165 - 177
Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology Raghuveera Kumar GoelKiven Erique Lukong NON-THEMATIC REVIEW 11 April 2016 Pages: 179 - 199
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer Wenli LiuGriffin P. Rodgers NON-THEMATIC REVIEW 13 May 2016 Pages: 201 - 212
Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis Marek Z. WojtukiewiczDominika HempelKenneth V. Honn NON-THEMATIC REVIEW 17 May 2016 Pages: 213 - 233
Deciphering the function of non-coding RNAs in prostate cancer João Ramalho-CarvalhoBastian FrommCarmen Jerónimo NON-THEMATIC REVIEW 25 May 2016 Pages: 235 - 262
Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design Jason K. SicklickPaul T. FantaRazelle Kurzrock CLINICAL 09 February 2016 Pages: 263 - 275
Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? Cyrus ChargariKaryn A. GoodmanNicolas Magne Clinical 12 March 2016 Pages: 277 - 288
miR clusters target cellular functional complexes by defining their degree of regulatory freedom Jörg HaierAnda StröseRichard Hummel Clinical 12 March 2016 Pages: 289 - 322
Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases Minetta C. LiuJavier CortésJoyce O’Shaughnessy Clinical 29 March 2016 Pages: 323 - 332
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management Kosei NakajimaDong Hyo KhoAvraham Raz Clinical 11 April 2016 Pages: 333 - 346
